TrialCancer treatment and research communications2019

Randomized trial of oral cyclophosphamide versus oral cyclophosphamide with celecoxib for recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Rohan Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.